Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sandler

Showing results (781-790 of 870) with videos related to

Pageof 87
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2025
A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate CancerSebastian Medina, Naoto Tokuyama, Kamal Hammouda, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of LifeHiram A Gay, Martin G Sanda, Jingxia Liu, et al.
European Urology|September 13, 2015
Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08Justin C Voog, Rebecca Paulus, William U Shipley, et al.
JAMA Oncology|February 15, 2019
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical TrialDeborah W Bruner, Stephanie L Pugh, W Robert Lee, et al.
Science Advances|July 3, 2026
Single-cell transcriptomic analysis reveals tumor-immune determinants of lymph node colonization and progression in thyroid cancerAnthony T Nguyen, Jolene Viramontes, Isaiah Vazquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910Thomas M Pisansky, Daniel Hunt, Leonard G Gomella, et al.
The Journal of Pathology|December 11, 2024
Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimensBrennan T Flannery, Howard M Sandler, Priti Lal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2019
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902Daniel A Hamstra, Stephanie L Pugh, Herbert Lepor, et al.
Urologic Oncology|July 7, 2016
Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01Raymond H Mak, Daniel Hunt, Jason A Efstathiou, et al.
JAMA Oncology|October 17, 2018
Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysisAmar U Kishan, Xiaoyan Wang, Wendy Seiferheld, et al.
Pageof 87

Showing results (781-790 of 870) with videos related to

Sort By:
Pageof 87
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2025
A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate CancerSebastian Medina, Naoto Tokuyama, Kamal Hammouda, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of LifeHiram A Gay, Martin G Sanda, Jingxia Liu, et al.
European Urology|September 13, 2015
Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08Justin C Voog, Rebecca Paulus, William U Shipley, et al.
JAMA Oncology|February 15, 2019
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical TrialDeborah W Bruner, Stephanie L Pugh, W Robert Lee, et al.
Science Advances|July 3, 2026
Single-cell transcriptomic analysis reveals tumor-immune determinants of lymph node colonization and progression in thyroid cancerAnthony T Nguyen, Jolene Viramontes, Isaiah Vazquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910Thomas M Pisansky, Daniel Hunt, Leonard G Gomella, et al.
The Journal of Pathology|December 11, 2024
Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimensBrennan T Flannery, Howard M Sandler, Priti Lal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2019
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902Daniel A Hamstra, Stephanie L Pugh, Herbert Lepor, et al.
Urologic Oncology|July 7, 2016
Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01Raymond H Mak, Daniel Hunt, Jason A Efstathiou, et al.
JAMA Oncology|October 17, 2018
Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysisAmar U Kishan, Xiaoyan Wang, Wendy Seiferheld, et al.
Pageof 87